
    
      Patients will receive thalidomide in the oral form each night before bed. The dose of
      thalidomide will be increased each week until week 7 as long as there are no significant side
      effects.

      Routine physical examinations and blood tests will be done to monitor the effect of treatment
      and the toxicities encountered, if any, and provide the available treatments for side effects
      accordingly. Blood tests will be done to monitor the tumor response.
    
  